SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-017102
Filing Date
2020-07-09
Accepted
2020-07-09 17:02:50
Documents
3
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea124021-6k_therapix.htm 6-K 10443
2 PRESS RELEASE ea124021ex99-1_therapix.htm EX-99.1 6449
3 GRAPHIC image_001.jpg GRAPHIC 11678
  Complete submission text file 0001213900-20-017102.txt   34170
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201021057
SIC: 2834 Pharmaceutical Preparations